Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hok Sum Chan, Fanny Wai San Ko, Johnny Wai Man Chan, Kah Lin Choo, Loletta Kit Ying So, David Chi Leung Lam, Kit Man Sin, Wei Yin Wong, Yuk Lun Cheng & Maureen Mo Lin Wong. (2023) Hospital Burden of Chronic Obstructive Pulmonary Disease in Hong Kong – The Trend from 2006 to 2014. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 507-519.
Read now
Read now
Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Read now
Priyamvada S Chukowry, Daniella A Spittle & Alice M Turner. (2021) Small Airways Disease, Biomarkers and COPD: Where are We?. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 351-365.
Read now
Read now
Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Kyung Ho Kang, Chin Kook Rhee, Seoung Ju Park & Jae Jeong Shim. (2018) Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3381-3387.
Read now
Read now
Jianmin Jin, Shuling Li, Wenling Yu, Xiaofang Liu & Yongchang Sun. (2018) Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 375-384.
Read now
Read now
Cheong-Ju Kim, Hyoung-Kyu Yoon, Myung-Jae Park, Kwang-Ha Yoo, Ki-Suck Jung, Jeong-Woong Park, Seong Yong Lim, Jae Jeong Shim, Yong Chul Lee, Young-Sam Kim, Yeon-Mok Oh, Song Kim & Chul-Gyu Yoo. (2017) Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1589-1596.
Read now
Read now
Articles from other publishers (27)
Rosario Lineros, Lourdes Fernández-Delgado, Antonio Vega-Rioja, Pedro Chacón, Bouchra Doukkali, Javier Monteseirin & David Ribas-Pérez. (2023) Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids. Biomedicines 11:5, pages 1243.
Crossref
Crossref
Meropi Karakioulaki & Daiana Stolz. (2023) Differenzierte COPD-Diagnostik: Auf dem Weg zur Eliminierung der COPD. Deutsches Ärzteblatt Online.
Crossref
Crossref
Gordon Cupido & Gunar Günther. (2023) Post tuberculosis lung disease and tuberculosis sequelae: A narrative review. Indian Journal of Tuberculosis.
Crossref
Crossref
Ian A. Yang, Janet G. Shaw, Edward K.H. Stephens, Tian Mun Chee, Edwina E. Duhig, Rayleen V. Bowman, Gerard N. Olive, Henry M. Marshall & Kwun M. Fong. 2022. Lung Diseases and Cancer. Lung Diseases and Cancer
91
104
.
Katarina Kamenar, Shakir Hossen, Akshay N Gupte, Trishul Siddharthan, Suzanne Pollard, Muhammad Chowdhury, Adolfo L Rubinstein, Vilma E Irazola, Laura Gutierrez, J Jaime Miranda, Antonio Bernabe-Ortiz, Dewan Alam, Bruce Kirenga, Rupert C Jones, Frederik van Gemert, Robert A Wise & William Checkley. (2022) Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax 77:11, pages 1088-1097.
Crossref
Crossref
Daiana Stolz, Takudzwa Mkorombindo, Desiree M Schumann, Alvar Agusti, Samuel Y Ash, Mona Bafadhel, Chunxue Bai, James D Chalmers, Gerard J Criner, Shyamali C Dharmage, Frits M E Franssen, Urs Frey, MeiLan Han, Nadia N Hansel, Nathaniel M Hawkins, Ravi Kalhan, Melanie Konigshoff, Fanny W Ko, Trisha M Parekh, Pippa Powell, Maureen Rutten-van Mölken, Jodie Simpson, Don D Sin, Yuanlin Song, Bela Suki, Thierry Troosters, George R Washko, Tobias Welte & Mark T Dransfield. (2022) Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. The Lancet 400:10356, pages 921-972.
Crossref
Crossref
Qing Li, Haoran Li, Jun An, Xuxia Zhang, Wei Wang, Yufeng Wang, Zhongtan Xue, Shanshan Li & Yu Pang. (2022) Transition between Mycobacterium tuberculosis and nontuberculous mycobacteria in recurrent “tuberculosis” patients. European Journal of Clinical Microbiology & Infectious Diseases.
Crossref
Crossref
Kumar Shanmugasundaram, Anjana Talwar, Karan Madan & Geetanjali Bade. (2022) Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae. Tuberculosis and Respiratory Diseases 85:2, pages 175-184.
Crossref
Crossref
Surinder K. Jindal. (2022) Is pulmonary tuberculosis a true risk-factor for chronic obstructive pulmonary disease?. Indian Journal of Tuberculosis 69:2, pages 131-133.
Crossref
Crossref
Kamlesh Bhatt, Madhuri Bhagavathula, Sheetal Verma, Graham S. Timmins, Vojo P. Deretic, Jerrold J. Ellner & Padmini Salgame. (2021)
Rapamycin modulates pulmonary pathology in a murine model of
Mycobacterium tuberculosis
infection
. Disease Models & Mechanisms 14:10.
Crossref
Crossref
Da Jung Kim, Jee Youn Oh, Chin Kook Rhee, Seoung Ju Park, Jae Jeong Shim & Joo-Youn Cho. (2021) Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD. Frontiers in Medicine 8.
Crossref
Crossref
DhruvM Shah, RavishM Kshatriya & Rajiv Paliwal. (2021) Comparison of demographic, clinical, spirometry, and radiological parameters between smoking and non-smoking COPD patients in rural Gujarat, India. Journal of Family Medicine and Primary Care 10:9, pages 3343.
Crossref
Crossref
Smrutirekha Swain, Sudarsan Pothal, Aurobindo Behera, Rekha Manjhi, Pravati Dutta & Gourahari Pradhan. (2021) Treatment outcome among Post TB obstructive airways diseases and COPD: A prospective cohort study. Journal of Family Medicine and Primary Care 10:9, pages 3411.
Crossref
Crossref
John R. Hurst & Trishul Siddharthan. 2021. Handbook of Global Health. Handbook of Global Health
439
458
.
Maria Eugenia Laucho-Contreras & Mark Cohen-Todd. (2020) Early diagnosis of COPD: myth or a true perspective. European Respiratory Review 29:158, pages 200131.
Crossref
Crossref
Yanqing Le, Wenli Cao, Lu Zhou, Xin Fan, Qiangui Liu, Fusheng Liu, Xiaoyan Gai, Chun Chang, Jing Xiong, Yafei Rao, Aling Li, Wei Xu, Beibei Liu, Tong Wang, Beinan Wang & Yongchang Sun. (2020) Infection of Mycobacterium tuberculosis Promotes Both M1/M2 Polarization and MMP Production in Cigarette Smoke-Exposed Macrophages. Frontiers in Immunology 11.
Crossref
Crossref
I. I. Dubrovskaya, N. V. Bagisheva, A. V. Mordyk, E. Y. Nebesnaya & L. I. Bakhshieva. (2020) Detection and differential diagnosis of tuberculosis in patients of the pulmonary department with community-acquired pneumonia and chronic obstructive pulmonary disease. Russian Pulmonology 30:3, pages 305-311.
Crossref
Crossref
Chu-Chang Ku, Chien-Chou Chen, Simon Dixon, Hsien Ho Lin & Peter J Dodd. (2020) Patient pathways of tuberculosis care-seeking and treatment: an individual-level analysis of National Health Insurance data in Taiwan. BMJ Global Health 5:6, pages e002187.
Crossref
Crossref
John R. Hurst & Trishul Siddharthan. 2020. Handbook of Global Health. Handbook of Global Health
1
20
.
E. P. Golubinskaya, T. G. Filonenko, A. V. Kubyshkin, Yu. A. Yermola, M. A. Kalfa, A. V. Gerashchenko & T. V. Kramar. (2019) Immunophenotype of the macrophage population in fibrous, cavernous pulmonary tuberculosis. Bulletin of Siberian Medicine 18:1, pages 190-200.
Crossref
Crossref
Piyush Baindara. (2019) Host-directed therapies to combat tuberculosis and associated non-communicable diseases. Microbial Pathogenesis 130, pages 156-168.
Crossref
Crossref
Ronan F. O’Toole. 2019. Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions. Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions
17
26
.
C. Lange, W. A. Alghamdi, M. H. Al-Shaer, S. Brighenti, A. H. Diacon, A. R. DiNardo, H. P. Grobbel, M. I. Gröschel, F. von Groote-Bidlingmaier, M. Hauptmann, J. Heyckendorf, N. Köhler, T. A. Kohl, M. Merker, S. Niemann, C. A. Peloquin, M. Reimann, U. E. Schaible, D. Schaub, V. Schleusener, T. Thye & T. Schön. (2018) Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of Internal Medicine 284:2, pages 163-188.
Crossref
Crossref
Александр Юрьевич Черников & Любовь Григорьевна Землянских. (2018) ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ БОЛЬНЫХ ТУБЕРКУЛЕЗОМ С МНОЖЕСТВЕННОЙ И ШИРОКОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТЬЮ ВОЗБУДИТЕЛЯ В СОЧЕТАНИИ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ, "Вестник Центрального научно-исследовательского института туберкулеза". Вестник ЦНИИТ:4, pages 24-30.
Crossref
Crossref
Hye Jung Park, Min Kwang Byun, Hyung Jung Kim, Chul Min Ahn, Deog Kyeom Kim, Yu Il Kim, Jin Young Oh, Hyoung Kyu Yoon, Kwang-Ha Yoo & Ki Suck Jung. (2018) History of pulmonary tuberculosis affects the severity and clinical outcomes of COPD. Respirology 23:1, pages 100-106.
Crossref
Crossref
Reza Eslami Manoochehri, Sayyed Gholamreza Mortazavimoghaddam, Mohammad Hasan Namaei & Mahmod Zardast. (2017) Alterationsinserum Antitrypsin Level and Its Association with Pulmonary Complications Among Patients with Lung Tuberculosis. Modern Care Journal 14:2.
Crossref
Crossref
NirmalKumar Jain. (2017) Chronic obstructive pulmonary disease and tuberculosis. Lung India 34:5, pages 468.
Crossref
Crossref